Chapters

Transcript

Video

Can brensocatib be used in both patients who have new onset NCFBE as well as in older patients who have longstanding NCFBE with poor prognostic factors? Did subgroup analyses from ASPEN or WILLOW provide any direction regarding this question?


Created by

CMEducation Resources iQ&A Bronchiectasis (NCFBE) Pulmonary Medicine Intelligence Zone

Presenter

Prof. Francesco Blasi, MD, FERS

Prof. Francesco Blasi, MD, FERS

Professor of Respiratory Medicine
Department of Pathophysiology and Transplantation, 
Vice Rector for Relations with the National Health Service
University of Milan
Dean of the School of Medicine, University of Milan
Milan, Italy